UHyasen uthathe inxaxheba ngempumelelo kwi-CACLP

I-Hyasen Biotech iye yaya kumboniso we-CACLP wama-21 eChongqing ukusuka kwi-3.15-3.18.

Umboniso wama-21 weCACLP upheliswe ngempumelelo eChongqing.Lo mboniso ujolise ekukhuthazeni unxibelelwano lobugcisa kunye nenkqubela phambili yezoshishino kwi-In Vitro Diagnostic industry.Lo mboniso uqokelele ababonisi be-1,000 kunye neendwendwe ezingaphezu kwe-80,000.

Siye sakwazi ukudibana namaqabane ethu amaninzi, nawo awayeze kutyelela lo mboniso.Kwaye sifikelele kwintsebenziswano entsha kumboniso.

Ukongeza, abathengi abaninzi, abandwendwela lo mboniso, nabo bazazi iimveliso kunye neenkonzo zethu, kwaye siye safumana amaqabane amatsha entsebenziswano.

Ukuza kuthi ga ngoku, i-2024 CACLP ifikelele kwisigqibo esiyimpumelelo.Kwixesha elizayo, siya kugxininisa ekuhlakuleleni kwintsimi ye-IVD, kwaye sihlolisise amathuba amaninzi okuphuhliswa kwe-In Vitro Diagnostic industry!